Related Experiment Videos
Rhabdomyoma of the orbit: a case report
JaeSung Myung1, In-One Kim, Jung-Eun Chun
1Department of Radiology, Institute of Radiation Medicine, Seoul National University Medical Research Centre, Seoul, Korea.
Abstract:
Extracardiac rhabdomyoma is a rare benign neoplasm of skeletal muscle differentiation. It occurs most often in the head and neck, but only four cases with occurrence in the orbit have been reported in the literature. A 3-month-old infant presented with right proptosis. MRI showed an enhancing intraconal mass in the right orbit, which appeared isointense on TI-weighted images and hypointense on T2-weighted images. The mass was removed and diagnosed as rhabdomyoma. It recurred 8 months after surgery. MR imaging features can be helpful for the diagnosis.
Insights
Extracardiac rhabdomyoma, a rare orbital tumor, can cause proptosis in infants. Early MRI diagnosis is crucial as this benign neoplasm may recur after surgical removal.
Area of Science:
- Ophthalmology
- Pathology
- Radiology
Background:
- Extracardiac rhabdomyoma is a rare benign neoplasm originating from skeletal muscle.
- Orbital involvement is exceptionally rare, with only four previously reported cases.
- This highlights the rarity of rhabdomyoma in the orbital region.
Observation:
- A 3-month-old infant presented with right proptosis.
- Magnetic Resonance Imaging (MRI) revealed an enhancing intraconal orbital mass.
- The mass demonstrated characteristic signal intensities: isointense on T1-weighted and hypointense on T2-weighted images.
Findings:
- The surgically removed mass was diagnosed as rhabdomyoma.
- Recurrence of the rhabdomyoma was observed 8 months post-surgery.
- This case underscores the potential for recurrence even after complete excision.
Implications:
- Characteristic MRI findings can aid in the preoperative diagnosis of orbital rhabdomyoma.
- Awareness of this rare entity and its imaging features is important for ophthalmologists and radiologists.
- Close follow-up is recommended due to the risk of tumor recurrence.